// App-Quantinova.ai

P858 : Crohn’s disease is characterised by a fungal dysbiosis

Researchers

Presenter

  • A Frau

Principal Investigators

  • D Jonkers

  • J Penders

  • M Pierik

  • U Z Ijaz

  • B Campbell

  • A Darby

  • J Kenny

  • N Hall

  • C Probert

Medical Centers

  • University of Liverpool, Cellular and Molecular Physiology, Liverpool, United Kingdom

  • Maastricht University, Internal Medicine, section of Gastroenterology, Maastricht, The Netherlands

  • University of Glasgow, Infrastructure and Environment, Glasgow, UK

  • University of Liverpool, Functional and Comparative Genomics, Liverpool, UK

  • Earlham Institute, Norwich, UK

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A